Knights of Columbus Asset Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285K	Sell	4,940 -1,780	-26%	-$102K	0.01%	333
2026 Q1	$408K	Buy	6,720 +1,327	+25%	+$77.4K	0.02%	323
2025 Q4	$291K	Buy	+5,393	New	+$259K	0.02%	333
2023 Q1	–	Sell	-162,404	Closed	-$11.7M	–	364
2022 Q4	$11.7M	Buy	162,404 +25,613	+19%	+$1.93M	1.21%	11
2022 Q3	$9.72M	Sell	136,791 -7,584	-5%	-$550K	0.99%	13
2022 Q2	$11.1M	Buy	144,375 +12,951	+10%	+$986K	1.11%	11
2022 Q1	$9.6M	Buy	131,424 +2,266	+2%	+$152K	0.82%	15
2021 Q4	$8.05M	Sell	129,158 -6,267	-5%	-$368K	0.65%	31
2021 Q3	$8.01M	Buy	135,425 +19,622	+17%	+$1.29M	0.72%	20
2021 Q2	$7.74M	Buy	115,803 +46,504	+67%	+$3.03M	0.71%	18
2021 Q1	$4.38M	Sell	69,299 -974	-1%	-$60.6K	0.43%	83
2020 Q4	$4.36M	Buy	70,273 +2,428	+4%	+$149K	0.46%	68
2020 Q3	$4.09M	Buy	67,845 +47,620	+235%	+$2.87M	0.51%	50
2020 Q2	$1.19M	Sell	20,225 -495	-2%	-$29.6K	0.15%	223
2020 Q1	$1.16M	Buy	+20,720	New	+$1.27M	0.15%	218

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Knights of Columbus Asset Advisors's BMY Position: Q2 2026 in Review

Knights of Columbus Asset Advisors reduced its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, selling an estimated $102K and leaving 4,940 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #333.

Knights of Columbus Asset Advisors first reported a position in BMY in Q1 2020 and has held it in 15 quarters since. The position peaked at $11.7M in Q4 2022. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Knights of Columbus Asset Advisors held 4,940 shares of Bristol-Myers Squibb worth $285K as of Q2 2026.
Knights of Columbus Asset Advisors sold 1,780 Bristol-Myers Squibb shares in Q2 2026, an estimated $102K.
Bristol-Myers Squibb made up 0.01% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #333 holding.
Knights of Columbus Asset Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 15 quarters since.
Knights of Columbus Asset Advisors's Bristol-Myers Squibb position peaked at $11.7M in Q4 2022.
1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.